Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy
Public ClinicalTrials.gov record NCT07658976. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy of HIV PrEP and STI PEP for Young Men
Study identification
- NCT ID
- NCT07658976
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- HIV Prevention Trials Network
- Network
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Interventions
- HIV PrEP - choice of F/TDF, F/TAF, or CAB-LA Drug
- STI PEP - Doxycycline as Doxy-PEP Drug
- 3P mHealth package Behavioral
- Handout about HIV PrEP options available at the site Behavioral
- Standard-of-care HIV PrEP counseling from qualified study staff Behavioral
Drug · Behavioral
Eligibility (public fields only)
- Age range
- 18 Years to 29 Years
- Sex
- Male
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2026
- Primary completion
- Aug 31, 2029
- Completion
- Aug 31, 2029
- Last update posted
- Jun 21, 2026
2026 – 2029
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA Vine Street Clinic | Los Angeles | California | 90095 | — |
| Bronx Prevention Research Center CRS | The Bronx | New York | 10451 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07658976, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 21, 2026 · Synced Jun 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07658976 live on ClinicalTrials.gov.